Contemporary criteria for the selection of patients for percutaneous balloon mitral valvuloplasty.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 1767103)

Published in Heart on May 01, 2002

Authors

B D Prendergast, T R D Shaw, B Iung, A Vahanian, D B Northridge

Articles cited by this

Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med (1994) 5.14

Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg (1984) 4.45

Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J (1988) 4.01

ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol (1998) 3.58

Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation (1998) 2.65

Inoue balloon mitral valvuloplasty: long-term clinical and echocardiographic follow-up of a predominantly unfavourable population. Eur Heart J (2000) 1.77

The surgical treatment of mitral stenosis (mitral commissurotomy). Dis Chest (1949) 1.70

Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation (1999) 1.61

Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation (1999) 1.58

Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. Eur Heart J (2000) 1.45

Percutaneous mitral valvotomy with a metal dilatator. Lancet (1997) 1.40

Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation (1996) 1.35

Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol (1993) 1.17

Echocardiographic assessment of commissural calcium: a simple predictor of outcome after percutaneous mitral balloon valvotomy. J Am Coll Cardiol (1997) 1.07

Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvulotomy. J Am Coll Cardiol (1996) 1.04

Significance of commissural calcification on outcome of mitral balloon valvotomy. Heart (2000) 0.99

Mechanism of mitral valve area increase by in vitro single and double balloon mitral valvotomy. Am J Cardiol (1988) 0.95

Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol (1996) 0.91

Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation (1995) 0.89

Immediate and long-term outcome of percutaneous mitral valvotomy in patients 65 years and older. Circulation (1992) 0.88

Percutaneous mechanical mitral commissurotomy with a newly designed metallic valvulotome: immediate results of the initial experience in 153 patients. Circulation (1999) 0.88

Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol (1994) 0.85

Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. Am J Cardiol (2000) 0.84

Multicenter experience with balloon mitral commissurotomy. NHLBI Balloon Valvuloplasty Registry Report on immediate and 30-day follow-up results. The National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Participants. Circulation (1992) 0.84

Retrograde nontransseptal balloon mitral valvuloplasty. Immediate results and long-term follow-up. Circulation (1992) 0.83

Percutaneous mitral balloon valvotomy for recurrent mitral stenosis after surgical commissurotomy. Am J Cardiol (1995) 0.82

Farewell to surgical mitral commissurotomy for many patients. Circulation (1998) 0.81

Percutaneous mitral commissurotomy. Eur Heart J (1996) 0.81

Mitral balloon valvuloplasty for patients aged over 70 years: an alternative to surgical treatment. Age Ageing (1991) 0.79

Multivalve percutaneous balloon valvuloplasty. Cathet Cardiovasc Diagn (1989) 0.78

Articles by these authors

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet (2002) 8.10

Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation (2000) 4.46

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36

AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation (1996) 3.00

Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study. Eur Heart J (1999) 2.90

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet (2001) 2.23

5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med (1999) 2.10

Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA (1999) 2.08

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J (2002) 2.06

One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. Circulation (1996) 2.03

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87

Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation (1999) 1.83

Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74

Infective endocarditis in Europe: lessons from the Euro heart survey. Heart (2005) 1.70

Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation (1999) 1.61

Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J (2002) 1.59

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. Eur Heart J (1999) 1.57

Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. Heart (2006) 1.55

Percutaneous mitral commissurotomy in the elderly. Eur Heart J (1995) 1.53

Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol (2003) 1.52

Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation (2000) 1.48

Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur Heart J (1996) 1.47

Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. Eur Heart J (2000) 1.45

Silent T2* cerebral microbleeds: a potential new imaging clue in infective endocarditis. Neurology (2007) 1.45

[Risk factors management in 5708 ambulatory patients suffering from peripheral vascular disease followed in urban practices]. Arch Mal Coeur Vaiss (2005) 1.45

Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group. Eur Heart J (1997) 1.45

Association between liberalization of Scotland's liquor licensing laws and admissions for self poisoning in West Fife. Br Med J (Clin Res Ed) (1986) 1.43

Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries. J Am Coll Cardiol (1998) 1.42

Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Catheter Cardiovasc Interv (2006) 1.42

Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin. Heart (2009) 1.41

Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study. Eur Heart J (2000) 1.40

[Patent foramen ovale percutaneous closure: indications, techniques and results]. Ann Cardiol Angeiol (Paris) (2007) 1.39

Transfer of the posterior tricuspid leaflet and chordae for mitral valve repair. J Thorac Cardiovasc Surg (1995) 1.39

Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation (1996) 1.35

Valvular heart disease: the next cardiac epidemic. Heart (2010) 1.22

Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism. J Heart Valve Dis (1993) 1.19

Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Circulation (1994) 1.19

Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. Eur Heart J (2003) 1.16

Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol (1997) 1.15

Double mitral homograft for recurrent bacterial endocarditis of the mitral and tricuspid valves. J Heart Valve Dis (1994) 1.13

Severe coronary vasospasm associated with hyperthyroidism causing myocardial infarction. Br Heart J (1995) 1.10

Trends in analgesic self-poisoning in West-Fife, 1971-1985. Q J Med (1987) 1.09

Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Heart (2002) 1.02

Antegrade transseptal coronary angiography: an alternative technique in severe vascular disease. Cathet Cardiovasc Diagn (1998) 1.01

Early treatment with captopril after acute myocardial infarction. Br Heart J (1993) 1.00

Significance of commissural calcification on outcome of mitral balloon valvotomy. Heart (2000) 0.99

Specifics of technique in percutaneous mitral commissurotomy in a case of dextrocardia and situs inversus with mitral stenosis. Cathet Cardiovasc Diagn (1996) 0.98

The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failure. Eur Heart J (1992) 0.97

Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation (1999) 0.95

Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol (1999) 0.95

Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J (1999) 0.94

Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol (2000) 0.94

Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging. Cerebrovasc Dis (2013) 0.93

Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial. Circulation (2000) 0.93

Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials. Circulation (2001) 0.93

Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation (2000) 0.92

A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study. Eur Heart J (2001) 0.92

Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol (1996) 0.91

Skin reactions to long-term transdermal clonidine. Lancet (1987) 0.91

Value of multiplane transesophageal echocardiography in determining aortic valve area in aortic stenosis. Am J Cardiol (1996) 0.90

The influence of endothelium-derived nitric oxide on myocardial contractile function. Int J Cardiol (1995) 0.90

The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone. J Am Coll Cardiol (2001) 0.89

Exercise testing and exercise stress echocardiography in asymptomatic aortic valve stenosis. Heart (2008) 0.87

Cardiac arrhythmias during the combined use of intravenous aminophylline and terbutaline in status asthmaticus. Chest (1988) 0.87

[Mitral stenosis]. Ann Cardiol Angeiol (Paris) (2003) 0.87

Early assessment by transesophageal echocardiography of left atrial appendage function after percutaneous mitral commissurotomy. Am J Cardiol (1996) 0.86

Perfusion/ventilation mismatch during exercise in chronic heart failure: an investigation of circulatory determinants. Br Heart J (1995) 0.86

Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol (1994) 0.85

Diagnosis of left atrial thrombi in mitral stenosis--usefulness of ultrasound techniques compared with other methods. Eur Heart J (1991) 0.85

Three-dimensional transoesophageal echocardiography in aortic dissection. Heart (2009) 0.85

[Etiologic course of heart valve diseases surgically treated during 20 years in France]. Arch Mal Coeur Vaiss (1992) 0.84

Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. Am J Cardiol (2000) 0.84

Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR Am J Neuroradiol (2013) 0.84

The effect of left ventricular systolic function on long term survival in mitral and aortic regurgitation. J Heart Valve Dis (1995) 0.84

Congenital diverticulum of the right ventricle: report of two cases associated with other congenital heart defects. Am Heart J (1989) 0.83

Transoesophageal echocardiography in the assessment of percutaneous mitral commissurotomy. Eur Heart J (1991) 0.83

Dextropropoxyphene overdose. Epidemiology, clinical presentation and management. Med Toxicol Adverse Drug Exp (1988) 0.83

Aorto-cavitary fistulae in infective endocarditis: understanding a rare complication through collaboration. Eur Heart J (2004) 0.83

Role of antidiuretic hormone in impaired water excretion of patients with congestive heart failure. J Clin Endocrinol Metab (1984) 0.83

The growing burden of infective endocarditis in the elderly. Eur Heart J (2003) 0.83

Images in cardiology. Needle embolism in an intravenous drug user. Heart (2006) 0.83

Transoesophageal echocardiographic assessment of primum, secundum and sinus venosus atrial septal defects. Int J Cardiol (1991) 0.83

Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. Clin Sci (Lond) (1994) 0.82

Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition. Eur Heart J (1998) 0.82

[Isolated carcinoid tumor of the ovary disclosed by tricuspid insufficiency]. Arch Mal Coeur Vaiss (2003) 0.82

Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. J Heart Valve Dis (1993) 0.82

[Listeria monocytogenes endocarditis in a patient with mechanical valve prosthesis]. Presse Med (1990) 0.81

Echocardiography and indications for surgery. Eur Heart J (1995) 0.81

Drug eluting coronary stents. BMJ (2002) 0.81

Argatroban and alteplase in patients with acute myocardial infarction: the ARGAMI Study. J Thromb Thrombolysis (2000) 0.81